Cancer disproportionately impacts adults living in rural areas
By Xcenda
Cancer is the second most common cause of death in the United States (US). A total of 1.9 million new cancer
cases and 610,000 deaths from cancer are expected in the US in 2022. Detecting cancer early, before it spreads
throughout the body, saves lives. Currently, only 5 types of cancer have commonly available screenings, which
leaves too many cancers with no way of being detected early. In fact, more than 70% of cancer deaths are due
to those cancers with no recommended screening test. Those living in rural areas often face greater public health challenges, as they have more limited access to
healthcare, are less likely to be insured, and are more likely to live in poverty. Those challenges can lead to
increased late-stage cancer incidence and cancer deaths. While cancer mortality rates across the nation have
been decreasing, this decline has not been experienced equally. For many rural populations, cancer mortality is
not decreasing; it is steady and, in some cases, rising. This issue brief seeks to compare the rates of diagnosed cancers in metropolitan vs non-metropolitan areas to
help quantify the disparity in cancer burden for patients living in non-metro areas.
Funding for this research was provided by National Grange; editorial control was maintained by AmerisourceBergen/Xcenda.

